HepaCheC® is considered as a complementary diagnostic method to the elevated AFP or other HCC diagnostic tests. A preliminary study (1) showed very promising results with significant discrimination between cirrhosis and HCC.

We are currently planning and performing post-market performance follow-up studies on HepaCheC to further validate its usefulness in diagnosis of HCC. 

1. Åström et al, PLoS One 2017;12(3):e0173897